GCN2 in the Brain Programs PPARγ2 and Triglyceride Storage in the Liver during Perinatal Development in Response to Maternal Dietary Fat

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Xu, Xu ^a   Hu, Jingjie ^a   McGrath, Barbara C ^a   Cavener, Douglas R ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GCN2 PROTEIN; HISTONE H3; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROTEIN KINASE R; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CIDEA GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; EPIGENETICS; FAT INTAKE; FATTY ACID OXIDATION; FATTY LIVER; FETUS; FSP27 GENE; GCN2 GENE; GENE; GENE REPRESSION; HISTONE METHYLATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID METABOLISM; LIPID STORAGE; LIVER; MATERNAL NUTRITION; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PERINATAL DEVELOPMENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2 GENE; PROGENY; PROMOTER REGION;

ANIMALS; BRAIN; DIETARY FATS; FEMALE; FETUS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR GAMMA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; TRIGLYCERIDES;

EID: 84885405485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075917     Document Type: Article

References (65)

1. Cohen JC, Horton JD, Hobbs HH, (2011) Human fatty liver disease: old questions and new insights. Science 332: 1519-1523.
2. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, et al. (2003) Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111: 737-747.
3. Bell M, Wang H, Chen H, McLenithan JC, Gong DW, et al. (2008) Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57: 2037-2045.
4. Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, et al. (2008) Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 283: 14355-14365.
5. Matsusue K, (2010) A physiological role for fat specific protein 27/cell death-inducing DFF45-like effector C in adipose and liver. Biol Pharm Bull 33: 346-350.
6. Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, et al. (2007) Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 282: 34213-34218.
7. Brasaemle DL, Dolios G, Shapiro L, Wang R, (2004) Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem 279: 46835-46842.
8. Martin S, Parton RG, (2006) Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7: 373-378.
9. Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, et al. (2009) Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 1: 280-287.
10. Zweytick D, Athenstaedt K, Daum G, (2000) Intracellular lipid particles of eukaryotic cells. Biochim Biophys Acta 1469: 101-120.
11. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, et al. (2008) FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 118: 2808-2821.
12. Puri V, Virbasius JV, Guilherme A, Czech MP, (2008) RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27. Acta Physiol (Oxf) 192: 103-115.
13. Liu K, Zhou S, Kim JY, Tillison K, Majors D, et al. (2009) Functional analysis of FSP27 protein regions for lipid droplet localization, caspase-dependent apoptosis, and dimerization with CIDEA. Am J Physiol Endocrinol Metab 297: E1395-1413.
14. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, et al. (2008) Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 7: 302-311.
15. Uno K, Yamada T, Ishigaki Y, Imai J, Hasegawa Y, et al. (2011) Hepatic peroxisome proliferator-activated receptor-{gamma}-fat-specific protein 27 pathway contributes to obesity-related hypertension via afferent vagal signals. Eur Heart J.
16. Bocher V, Pineda-Torra I, Fruchart JC, Staels B, (2002) PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann N Y Acad Sci 967: 7-18.
17. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, et al. (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16: 22-26.
18. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, et al. (2005) The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes 54: 1706-1716.
19. Yamazaki T, Shiraishi S, Kishimoto K, Miura S, Ezaki O, (2010) An increase in liver PPARgamma2 is an initial event to induce fatty liver in response to a diet high in butter: PPARgamma2 knockdown improves fatty liver induced by high-saturated fat. J Nutr Biochem 22: 543-553.
20. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR, (2005) PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288: E1195-1205.
21. White CL, Purpera MN, Morrison CD, (2009) Maternal obesity is necessary for programming effect of high-fat diet on offspring. Am J Physiol Regul Integr Comp Physiol 296: R1464-1472.
22. McMillen IC, Edwards LJ, Duffield J, Muhlhausler BS, (2006) Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity. Reproduction 131: 415-427.
23. Thompson NM, Norman AM, Donkin SS, Shankar RR, Vickers MH, et al. (2007) Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes. Endocrinology 148: 2345-2354.
24. Levin BE, (2006) Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos Trans R Soc Lond B Biol Sci 361: 1107-1121.
25. Levin BE, (2000) The obesity epidemic: metabolic imprinting on genetically susceptible neural circuits. Obes Res 8: 342-347.
26. Howie GJ, Sloboda DM, Kamal T, Vickers MH, (2009) Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol 587: 905-915.
27. Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, et al. (2010) Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 52: 913-920.
28. Oben JA, Patel T, Mouralidarane A, Samuelsson AM, Matthews P, et al. (2010) Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun 394: 24-28.
29. Hyatt MA, Gardner DS, Sebert S, Wilson V, Davidson N, et al. (2011) Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring. Reproduction 141: 119-126.
30. Vucetic Z, Kimmel J, Reyes TM, (2011) Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain. Neuropsychopharmacology 36: 1199-1206.
31. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM, (2010) Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 151: 4756-4764.
32. Levin BE, (2000) Metabolic imprinting on genetically predisposed neural circuits perpetuates obesity. Nutrition 16: 909-915.
33. Levin BE, (2009) Synergy of nature and nurture in the development of childhood obesity. Int J Obes (Lond) 33Suppl 1: S53-56.
34. Wolfner M, Yep D, Messenguy F, Fink GR, (1975) Integration of amino acid biosynthesis into the cell cycle of Saccharomyces cerevisiae. J Mol Biol 96: 273-290.
35. Dever TE, Feng L, Wek RC, Cigan AM, Donahue TF, et al. (1992) Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68: 585-596.
36. Wek RC, Jackson BM, Hinnebusch AG, (1989) Juxtaposition of domains homologous to protein kinases and histidyl-tRNA synthetases in GCN2 protein suggests a mechanism for coupling GCN4 expression to amino acid availability. Proc Natl Acad Sci U S A 86: 4579-4583.
37. Zhang P, McGrath BC, Reinert J, Olsen DS, Lei L, et al. (2002) The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol 22: 6681-6688.
38. Hao S, Sharp JW, Ross-Inta CM, McDaniel BJ, Anthony TG, et al. (2005) Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex. Science 307: 1776-1778.
39. Maurin AC, Jousse C, Averous J, Parry L, Bruhat A, et al. (2005) The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores. Cell Metab 1: 273-277.
40. Guo F, Cavener DR, (2007) The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab 5: 103-114.
41. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
42. Hu T, Foxworthy P, Siesky A, Ficorilli JV, Gao H, et al. (2005) Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha. Endocrinology 146: 5380-5387.
43. Lazarow PB, (1981) Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol 72: 315-319.
44. Viswanadha S, Londos C, (2006) Optimized conditions for measuring lipolysis in murine primary adipocytes. J Lipid Res 47: 1859-1864.
45. Yamazaki H, Arai M, Matsumura S, Inoue K, Fushiki T, (2002) Intracranial administration of transforming growth factor-beta3 increases fat oxidation in rats. Am J Physiol Endocrinol Metab 283: E536-544.
46. Cho YW, Hong S, Jin Q, Wang L, Lee JE, et al. (2009) Histone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesis. Cell Metab 10: 27-39.
47. Barker DJ, (1990) The fetal and infant origins of adult disease. BMJ 301: 1111.
48. McMillen IC, Muhlhausler BS, Duffield JA, Yuen BS, (2004) Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proc Nutr Soc 63: 405-412.
49. Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM, (2006) Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology 147: 1480-1487.
50. Flach RJ, Qin H, Zhang L, Bennett AM, (2011) Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27. J Biol Chem 286: 22195-22202.
51. Samuel VT, Petersen KF, Shulman GI, (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375: 2267-2277.
52. Kim JY, Liu K, Zhou S, Tillison K, Wu Y, et al. (2008) Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am J Physiol Endocrinol Metab 294: E654-667.
53. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, et al. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956.
54. Lee JH, Giannikopoulos P, Duncan SA, Wang J, Johansen CT, et al. (2011) The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat Med 17: 812-815.
55. Gabory A, Attig L, Junien C, (2011) Epigenetic mechanisms involved in developmental nutritional programming. World J Diabetes 2: 164-175.
56. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, et al. (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7: 249-257.
57. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3: e64.
58. Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, et al. (2005) Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 436: 1166-1173.
59. Wek SA, Zhu S, Wek RC, (1995) The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol Cell Biol 15: 4497-4506.
60. Berlanga JJ, Ventoso I, Harding HP, Deng J, Ron D, et al. (2006) Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses. Embo J 25: 1730-1740.
61. Deng J, Harding HP, Raught B, Gingras AC, Berlanga JJ, et al. (2002) Activation of GCN2 in UV-irradiated cells inhibits translation. Curr Biol 12: 1279-1286.
62. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, et al. (2007) An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 5: 91-102.
63. Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, et al. (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11: 320-327.
64. Uno K, Yamada T, Ishigaki Y, Imai J, Hasegawa Y, et al. (2012) Hepatic peroxisome proliferator-activated receptor-gamma-fat-specific protein 27 pathway contributes to obesity-related hypertension via afferent vagal signals. Eur Heart J 33: 1279-1289.
65. Hales CN, Barker DJ, (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595-601.